Computational drug discovery technique targets microRNAs using genome sequencing

A team of chemists has developed a new computational drug discovery technique that targets microRNAs using genome sequencing. To demonstrate the technique, which the research team believes presents a new and efficient, general-use approach to targeted drug discovery, they developed a drug that caused cancer cells to attack themselves.

The potential for manipulating these microRNAs to control disease genetics was recently called, “the next innovation in pharmaceutical research”, for a number of reasons in a review of microRNA therapeutics. For one, according to the research team at Scripps, it enables the production of small molecule drugs that bind to specific RNA, and those small molecules can typically easily permeate cells — “a property not innate to oligonucleotides”.

Read the full, original story: Data mine your DNA to develop better drugs

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend